Amarin Corp PLC (AMRN)

Name: Amarin Corp PLC (AMRN) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

SEC name AMARIN CORP PLC\UK · CIK 0000897448 · Nasdaq · Pharmaceutical Preparations

Sector Manufacturing
Fiscal year ends Dec 31

For the year ended 2025-12-31, Amarin Corp PLC reported revenue of $213.65M. Revenue fell 6.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $186.23M.

Key ratios (year ended 2025-12-31)

56.6%

Gross margin

-23.5%

Operating margin

-18.2%

Net margin

-8.4%

Return on year-end equity

-6.5%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-08-03

Headquarters locality: Bedminster · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$186.23M	$213.65M	$228.61M	$306.91M	$369.19M	$583.19M	$614.06M	$429.75M	$229.21M	$181.10M	$130.08M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	$121.33M	$131.44M	$96.02M	$54.54M	$44.95M	$34.36M
Gross Profit	$78.14M	$120.87M	$81.38M	$165.54M	$242.48M	$461.86M	$482.62M	$333.74M	$174.67M	$136.15M	$95.72M
R&D Expense	$19.02M	$19.81M	$20.87M	$22.22M	$30.41M	$29.31M	$38.96M	$34.39M	$55.90M	$47.16M	$49.98M
Operating Income	-$40.77M	-$50.17M	-$91.80M	-$67.59M	-$105.87M	$10.50M	-$19.66M	-$24.28M	-$108.22M	-$45.55M	-$65.63M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$23.0K	$62.0K	$138.0K
EBITDA	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-$108.20M	-$45.49M	-$65.49M
Net Income	-$27.12M	-$38.80M	-$82.18M	-$59.11M	-$105.80M	$7.73M	-$18.00M	-$22.64M	-$116.44M	-$67.86M	-$86.35M
EPS (Diluted)	n/a	-$0.09	-$0.20	-$0.15	-$0.26	$0.02	-$0.05	-$0.07	-$0.39	-$0.25	-$0.41
Total Assets	$624.36M	$670.77M	$685.35M	$831.68M	$886.18M	$1.07B	$966.02M	$882.21M	$385.71M	$161.60M	$167.00M
Total Liabilities	$180.75M	$211.49M	$199.17M	$279.59M	$290.85M	$400.97M	$338.52M	$273.95M	$233.38M	$226.70M	$176.06M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$49.70M	$79.71M	$92.40M	$93.59M
Shareholders' Equity	$443.62M	$459.28M	$486.18M	$552.10M	$595.33M	$667.10M	$627.50M	$608.26M	$152.33M	-$65.10M	-$9.06M
Cash & Equivalents	$143.56M	$134.66M	$121.04M	$199.25M	$217.67M	$219.45M	$186.96M	$644.59M	$249.23M	$73.64M	$98.25M
Operating Cash Flow	$15.57M	$6.73M	-$31.02M	$6.88M	-$180.09M	-$66.54M	-$21.75M	-$9.37M	-$94.70M	-$32.84M	-$71.81M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	$252.0K	$2.48M	$58.0K	$12.0K	$21.0K
Free Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	-$22.00M	-$11.84M	-$94.76M	-$32.85M	-$71.84M
Shares Outstanding	420.04M	416.21M	411.58M	408.82M	408.82M	396.60M	392.54M	360.10M	325.85M	271.02M	269.36M
Weighted Average Diluted Shares	n/a	414.98M	410.94M	407.65M	401.15M	402.48M	381.76M	342.54M	297.24M	270.65M	211.87M
EPS (Basic)	n/a	-$0.09	-$0.20	-$0.15	-$0.26	$0.02	-$0.05	-$0.07	-$0.39	-$0.25	-$0.41

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView